Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
4.350
-0.070 (-1.58%)
At close: Jun 13, 2025, 4:00 PM
4.330
-0.020 (-0.46%)
After-hours: Jun 13, 2025, 7:30 PM EDT
Xeris Biopharma Holdings Employees
Xeris Biopharma Holdings had 394 employees as of December 31, 2024. The number of employees increased by 17 or 4.51% compared to the previous year.
Employees
394
Change (1Y)
17
Growth (1Y)
4.51%
Revenue / Employee
$564,850
Profits / Employee
-$114,406
Market Cap
696.67M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
XERS News
- 11 days ago - Xeris Unveils Strategy for Long-Term Growth and Value Creation at 2025 Analyst & Investor Day - Business Wire
- 25 days ago - Xeris Announces Details for Analyst & Investor Day - Business Wire
- 5 weeks ago - Xeris Biopharma Holdings, Inc. (XERS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Xeris Biopharma Reports Record First Quarter 2025 Financial Results - Business Wire
- 5 weeks ago - Xeris Biopharma Holdings: Looking For More Growth In Q1 Earnings - Seeking Alpha
- 6 weeks ago - Xeris Biopharma to Report First Quarter 2025 Financial Results on May 8, 2025 - Business Wire
- 2 months ago - Xeris Announces Changes to Its Board of Directors - Business Wire
- 3 months ago - Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid - Business Wire